Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830407) titled 'Pre-Clinical Validation of ChemoINTEL Unified Algorithm Chemotherapeutic Response Prediction in Patients With Colorectal Cancer' on Sept. 15.

Study Type: Observational [Patient Registry]

Primary Sponsor: Pierian Biosciences

Condition: Colorectal Cancer

Recruitment Status: Recruiting

Date of First Enrollment: April 21, 2026

Target Sample Size: 100

Countries of Recruitment: United Kingdom

To know more, visit https://clinicaltrials.gov/study/NCT07830407

Published by HT Digital Content Services with permission from Health Daily Digest....